TY  - GEN
AU  - Schön,Michael P
TI  - Efalizumab in the treatment of psoriasis: mode of action, clinical indications, efficacy, and safety
SN  - 0738-081X
PY  - 2009///0106
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antibodies, Monoclonal, Humanized
KW  - CD11a Antigen
KW  - immunology
KW  - Humans
KW  - Psoriasis
KW  - drug therapy
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.1016/j.clindermatol.2007.10.027
ER  -